Table A11:

Probabilistic Reference Case Analysis Results—MRgFUS Neurosurgery Versus No Surgery

	MRgFUS, Mean (95% CI)	No Surgery, Mean (95% CI)
Cost of primary surgery	$19,786	–
Cost of monitoring	$814	$814
Cost of medications	$1,096	$1,245
Cost of reoperation	$1,731	–
Cost of managing adverse events	$71	–
Total costs	$23,497 (−22,044–$25,287)	$2,060
Life-years	4.63	4.63
QALYs	3.70 (3.48–3.89)	3.23 (2.65–3.74)
Incremental cost	$21,438 (−19,985–$23,227)
Incremental life-years	0.00
Incremental QALYs	0.47 (0.10–0.90)
ICER (cost/QALY)	$45,817

Abbreviations: MRgFUS, magnetic resonance-guided focused ultrasound; QALY, quality-adjusted life-year.